Skip to content
Trouver

Medicine in DR Congo · official US FDA label

Hyfresh 2 mg/ml

Hyaluronate de sodium (hyaluronate) · solution ophtalmique

Authorized in DR Congo

Want to buy it?

Not in stock in our pharmacies right now. Trouver shows when it is back near you. The reservation pages are in French.

See the pharmacies

This is a US label.

The official US FDA label for hyaluronate (published as HYALURONATE SODIUM), effective June 9, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.

Official US FDA label for hyaluronate

Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.

Uses

Uses: Antioxidant and skin protectant,Anti aging and wrinkle reducer, Skin moisturizer and conditioner

Dosage

US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.

Serum 5ml x 4+Mincroneedle Stamp x 4 HOW TO USE: For best results, use every 2 weeks.Treatment time: 10-15 minutes. 1. Start with clean hands. Remove the sterile applicator from the packaging.Do not use if the sterile seal is broken. 2. Cleanse your face thoroughly with warm water and pat dry. 3. Prepare the device: Open the 5ml ampoule serum. Carefully fill the applicator's reservoir with the essence. Se- curely screw the top back on and gently shake 2-3 times to mix. 4. Remove the protective safety cover immediately before use. 5.Application technique: Begin at the center of your face, gently stamping outward.For optimal absorption, use a 50% overlapping pattern and repeat 2-3 times per area.

Warnings and precautions

Do not use on broken, irritated, or sensitive skin. Avoid contact with eyes. lf contact occurs,rinse immediately with plenty of water. Discontinue use immediately if discomfort or irritation occurs.

Where to find it in DR Congo

Not in stock in our pharmacies right now

Stock changes with every sale. Search by substance: a medicine with the same composition may be available.

Composition

SubstanceStrengthATC code
Hyaluronate de sodium (hyaluronate)2 mg/ml—

Marketing authorization in DR Congo

From the register of the ACOREP (the Congolese pharmaceutical regulatory authority).

  • Authorization number

    ACRP/CAB/DG/D11/00/BMH1344/2024

    Valid from August 14, 2024 until August 14, 2029

    Holder
    Jamjoom Pharmaceuticals Company, . Plot No. ME1:3, Phase V, Industrial City, P.O. Box 6267, Jeddah-21442, Kingdom of Saudi Arabia
    Manufacturer
    Jamjoom Pharmaceuticals Company, Plot No. ME1:3, Phase V, Industrial City, P.O. Box 6267, Jeddah-21442, Kingdom of Saudi Arabia
    Country
    Arabie saoudite

Sources

  • ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
  • ●English names of substances: RxNorm, U.S. National Library of Medicine.
  • ●Marketing authorizations: register of the ACOREP, DR Congo, version of February 4, 2026.

Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.